Jini Qiu
NHC Key Laboratory Of Myopia And Related Eye Diseases, Key Laboratory Of Myopia And Related Eye Diseases
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Secondary corneal amyloidosis in a patient with Meesmann corneal dystrophy.
Journal: Japanese journal of ophthalmology
Published: October 17, 2025
Three-dimensional assessment of posterior polymorphous corneal dystrophy with swept-source optical coherence tomography.
Journal: Quantitative imaging in medicine and surgery
Published: October 01, 2025
N6-methyladenosine (m6A) modification regulates HSPA1A and HSPA1B expression in Müller cells under high glucose stress.
Journal: Experimental eye research
Published: November 20, 2024
Rapid detection of guttae area using aniline blue staining in Fuchs endothelial corneal dystrophy mouse model.
Journal: Clinical and experimental pharmacology & physiology
Published: July 22, 2024
METTL3-m6A-mediated TGF-β signaling promotes Fuchs endothelial corneal dystrophy via regulating corneal endothelial-to-mesenchymal transition.
Journal: Cell death discovery
Published: July 20, 2024
Herpes Simplex Keratitis as a Complication of Pterygium Surgery.
Journal: The American journal of case reports
Published: February 24, 2024
Benchmarking four large language models' performance of addressing Chinese patients' inquiries about dry eye disease: A two-phase study.
Journal: Heliyon
Published: January 09, 2024
Single-cell RNA sequencing reveals the complex cellular niche of pterygium.
Journal: The ocular surface
Published: October 12, 2023
Long noncoding RNA ZFAS1: A novel anti-apoptotic target in Fuchs endothelial corneal dystrophy.
Journal: Experimental eye research
Published: September 20, 2023
Type 2 Diabetes Mellitus Makes Corneal Endothelial Cells Vulnerable to Ultraviolet A-Induced Oxidative Damage Via Decreased DJ-1/Nrf2/NQO1 Pathway.
Journal: Investigative ophthalmology & visual science
Published: November 16, 2022
Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation.
Piperlongumine alleviates corneal allograft rejection via suppressing angiogenesis and inflammation.
Journal: Frontiers in immunology
Published: November 06, 2022
Construction and verification of a hypoxia-related nine-gene prognostic model in uveal melanoma based on integrated single-cell and bulk RNA sequencing analyses.
Journal: Experimental eye research
Published: May 17, 2022
Last Updated: 09/26/2026